Pulmonx (LUNG) Asset Writedowns and Impairment (2019 - 2025)
Pulmonx (LUNG) reported Asset Writedowns and Impairment of $46000.0 for Q2 2025, down 97.29% year-over-year from $1.7 million in Q2 2024, and up 200.0% on a QoQ basis from -$46000.0 in Q1 2025.
Pulmonx (LUNG) has 7 years of Asset Writedowns and Impairment data on file, last reported at $46000.0 in Q2 2025.
- Quarterly Asset Writedowns and Impairment fell 97.29% year-over-year to $46000.0 in Q2 2025, while the trailing twelve-month figure through Sep 2025 was -$200000.0 (down 109.69% YoY) and the FY2024 annual result came in at $40000.0, up 167.8% from the prior year.
- Asset Writedowns and Impairment improved to $46000.0 in Q2 2025 per LUNG's latest filing, from -$46000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $1.7 million in Q2 2024 and bottomed at -$968000.0 in Q4 2021.
- The 5-year median for Asset Writedowns and Impairment is $55000.0 (2022), against an average of $127388.9.
- Peak annual rise in Asset Writedowns and Impairment reached 722.71% in 2024, while the deepest fall reached 20100.0% in 2024.
- Tracing LUNG's Asset Writedowns and Impairment over 5 years: stood at -$968000.0 in 2021, then soared by 143.39% to $420000.0 in 2022, then tumbled by 99.76% to $1000.0 in 2023, then tumbled by 20100.0% to -$200000.0 in 2024, then surged by 123.0% to $46000.0 in 2025.
- Per Business Quant, the three latest LUNG Asset Writedowns and Impairment figures stand at $46000.0 (Q2 2025), -$46000.0 (Q1 2025), and -$200000.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 46,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Mar 31, 2025 | -46,000.00 |
| Mar 31, 2025 | -46,000.00 |
| Dec 31, 2024 | -200,000.00 |
| Dec 31, 2024 | -200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 163,000.00 |
| Mar 31, 2024 | 163,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | -60,000.00 |
| Sep 30, 2023 | -60,000.00 |
| Jun 30, 2023 | -273,000.00 |
| Jun 30, 2023 | -273,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Dec 31, 2022 | 420,000.00 |
| Dec 31, 2022 | 420,000.00 |
| Sep 30, 2022 | 64,000.00 |
| Sep 30, 2022 | 64,000.00 |
| Jun 30, 2022 | -45,000.00 |
| Jun 30, 2022 | -45,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | -968,000.00 |
| Dec 31, 2021 | -968,000.00 |
| Sep 30, 2021 | 307,000.00 |
| Sep 30, 2021 | 307,000.00 |
| Jun 30, 2021 | 212,000.00 |
| Jun 30, 2021 | 212,000.00 |
| Mar 31, 2021 | 453,000.00 |
| Mar 31, 2021 | 453,000.00 |
| Dec 31, 2020 | 2.65 Mn |
| Dec 31, 2020 | 2.65 Mn |
| Sep 30, 2020 | -2.65 Mn |
| Sep 30, 2020 | -2.65 Mn |
| Jun 30, 2020 | 2.94 Mn |
| Jun 30, 2020 | 2.94 Mn |
| Mar 31, 2020 | 95,000.00 |
| Mar 31, 2020 | 95,000.00 |
| Dec 31, 2019 | -250,000.00 |
| Dec 31, 2019 | -250,000.00 |